| Thu, Dec 10, 2009 | | • | XOMA Presents Advantages of Its Multiple Antibody Formulation Technologies at Antibody Engineering Conference
GlobeNewswire (Thu, Dec 10)
| | • | Graft-Versus-Host Disease: Failures and Future Opportunities
at Seeking Alpha (Thu, Dec 10)
| | Wed, Dec 9, 2009 | | • | XOMA LTD /DE/ Files SEC form 8-K/A, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T
EDGAR Online (Wed, Dec 9)
| | • | XOMA Announces NASDAQ Matter Resolved With Letter of Reprimand
GlobeNewswire (Wed, Dec 9)
| | Mon, Dec 7, 2009 | | • | 4 More Stocks on Wall Street's Dollar Menu
at Motley Fool (Mon, Dec 7)
| | Thu, Nov 19, 2009 | | • | XOMA LTD /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra
EDGAR Online (Thu, Nov 19)
| | • | XOMA Receives NASDAQ Determination Letter
GlobeNewswire (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | • | Coverage initiated on XOMA Limited by Canaccord Adams
Briefing.com (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | • | XOMA Appoints Jim Neal Vice President of Business Development
GlobeNewswire (Tue, Nov 17)
| | Fri, Nov 13, 2009 | | • | Biotech Stock Mailbag: Cardium Therapeutics
at TheStreet.com (Fri, Nov 13)
| | • | XOMA LTD /DE/ Financials
EDGAR Online Financials (Fri, Nov 13)
| | Thu, Nov 12, 2009 | | • | XOMA 052 Selected as a Top Ten Project to Watch
GlobeNewswire (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | • | XOMA Announces Presentation at Lazard Healthcare Conference on November 18
GlobeNewswire (Wed, Nov 11)
| | Mon, Nov 9, 2009 | | • | XOMA LTD /DE/ Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
| | • | Doc Offers Top Hep C Drug Picks: BioBuzz
at TheStreet.com (Mon, Nov 9)
| | • | XOMA Ltd. Q3 2009 Earnings Call Transcript
at Seeking Alpha (Mon, Nov 9)
| | • | Xoma Waffles on Timing of Drug Partnership: BioBuzz
at TheStreet.com (Mon, Nov 9)
| | • | XOMA Reports 2009 Third Quarter Financial Results
GlobeNewswire (Mon, Nov 9)
| | • | Q3 2009 XOMA Ltd. Earnings Release - Before Market Open
CCBN (Mon, Nov 9)
| | Fri, Nov 6, 2009 | | • | Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For Investors
Wall Street Transcript (Fri, Nov 6)
|
Add XOMA News to My Yahoo!:
 
| |
|
0.83% Nasdaq 
Headlines
